|
|
||||||||
|
by the American Institute of Ultrasound in Medicine J Ultrasound Med 26:1209-1214 0278-4297
Sonographic Detection of Trisomy 13 in the First and Second Trimesters of PregnancyMayo Clinic College of Medicine, Rochester, Minnesota USA (W.J.W.); St Barnabas Medical Center, Livingston, New Jersey USA (R.C.M.); Maine Medical Center, Portland, Maine USA (J.R.W.); University of Kentucky, Lexington, Kentucky USA (W.F.H.); University of Minnesota, Minneapolis, Minnesota USA (Y.Y.); and Good Samaritan Medical Center, Cincinnati, Ohio USA (W.J.P.). Address correspondence to William J. Watson, MD, Department of Maternal-Fetal Medicine, Mayo Clinic College of Medicine, 200 First St SW, Charlton 3B, Rochester MN 55905 USA. E-mail: watson.william{at}mayo.edu
Objective. The purpose of this study was to examine sonographic findings in fetuses with trisomy 13. Methods. A retrospective review of the cytogenetic laboratory databases at 6 tertiary referral centers identified all cases of trisomy 13. The prenatal sonographic studies in fetuses of less than 22 weeks gestation, done before invasive testing for karyotype, were reviewed for anatomic and biometric findings. We defined abnormal fetal biometric findings as a biometric measurement (biparietal diameter, abdominal circumference, or femur length) below the fifth percentile in the second trimester. Results. There were 8 cases of trisomy 13 found in the first trimester and 54 cases found in the second trimester, a total of 62 in all. In the first trimester, 6 of 8 had an anomaly identified (4 with cystic hygroma). In the second trimester, 49 of 54 were identified by sonography; 45 had an anomaly, and 4 had an abnormal fetal biometric measurement without an anomaly. The 5 missed diagnoses had early gestational age (<17 weeks; n = 3) or an inadequate survey secondary to poor visualization. Overall, 22 of 54 fetuses with trisomy 13 had an abnormal biometric measurement. The most common anomalies detected in the second trimester were heart defects (n = 34), central nervous system anomalies (n = 30), facial clefts (n = 19), abnormal hands (n = 13), and genitourinary anomalies (n = 9). Conclusions. Targeted sonography identified abnormal fetal anatomy or abnormal biometric measurements in 95% of fetuses with trisomy 13 in the second trimester after 17 weeks gestation. A biometric measurement below the fifth percentile was noted in nearly half of cases in the second trimester.
Key Words: aneuploidy prenatal diagnosis sonography trisomy 13 Abbreviations: AC, abdominal circumference BPD, biparietal diameter CNS, central nervous system FL, femur length
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |